Clinical Trial Detail

NCT ID NCT01196390
Title Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

Therapies

Carboplatin + Paclitaxel + Trastuzumab

Carboplatin + Paclitaxel

Age Groups: senior adult

Additional content available in CKB BOOST